BNP PARIBAS FINANCIAL MARKETS - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 10 filers reported holding KAZIA THERAPEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$8,460
+125.0%
8,500
+157.7%
0.00%
Q2 2023$3,7603,2980.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Transform Wealth, LLC 106,245$35,0000.01%
UBS Group AG 1,546$5,0000.00%
Renaissance Technologies 34,325$115,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BREWIN DOLPHIN LTD 32$1070.00%
MORGAN STANLEY 63,017$210,0000.00%
AdvisorNet Financial, Inc 5$00.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders